64764-108 : Entyvio Pen 108 mg/.68ml Subcutaneous Injection, Solution
NDC: | 64764-108 |
Labeler: | Takeda Pharmaceuticals America, Inc. |
Product Type: | Human Prescription Drug |
Drug Name: | Entyvio Pen |
Dosage Form: | Subcutaneous Injection, Solution |
Application #: | BLA761133 |
Rev. Date: |
NDC Package Codes:
- 64764-108-21: 1 TRAY IN 1 CARTON (64764‑108‑21) / 1 SYRINGE IN 1 TRAY (64764‑108‑20) / .68 ML IN 1 SYRINGE
Active Ingredients:
- Vedolizumab
Dosage Strength:
- 108 mg/.68mL
Pharmaceutical Classes:
- Integrin Receptor Antagonist [EPC]
- Integrin Receptor Antagonists [MoA]
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 64764-107Next: 64764-119 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.